General Primary Care   

In other words, are there benefits to identifying URI pathogens that do not necessarily have targeted therapies (e.g., rhinovirus, non-COVID-19 Corona...

Do you extend the course of fidaxomicin past initial 10 days to at least 3-7 days after completion of antibiotics?

Would you expect the presence of antibodies to indicate either immunity from contracting the infection, or otherwise risk of transmitting a latent inf...

For example, do you find trending WBC, procalcitonin, CRP, etc., more or less helpful?